Chemed Co. (NYSE:CHE) Director Frank E. Wood sold 1,200 shares of the company’s stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $445.17, for a total value of $534,204.00. Following the transaction, the director now directly owns 1,457 shares in the company, valued at approximately $648,612.69. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Shares of CHE stock traded up $3.28 during mid-day trading on Wednesday, hitting $480.30. 58,348 shares of the stock were exchanged, compared to its average volume of 64,653. The company has a quick ratio of 0.64, a current ratio of 0.67 and a debt-to-equity ratio of 0.32. The company has a market cap of $7.59 billion, a PE ratio of 38.12, a price-to-earnings-growth ratio of 2.74 and a beta of 1.09. Chemed Co. has a 52-week low of $284.87 and a 52-week high of $485.15. The firm has a fifty day moving average of $446.50 and a 200 day moving average of $420.67.
Chemed (NYSE:CHE) last announced its quarterly earnings data on Tuesday, October 29th. The company reported $3.46 earnings per share for the quarter, beating analysts’ consensus estimates of $3.31 by $0.15. The company had revenue of $480.61 million for the quarter, compared to analyst estimates of $478.89 million. Chemed had a return on equity of 35.06% and a net margin of 11.14%. The firm’s revenue for the quarter was up 8.2% on a year-over-year basis. During the same quarter last year, the firm posted $3.07 EPS. Equities analysts predict that Chemed Co. will post 13.47 EPS for the current year.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Krane Funds Advisors LLC purchased a new stake in Chemed in the 2nd quarter valued at about $26,000. Harvest Fund Management Co. Ltd boosted its holdings in Chemed by 152.9% during the 2nd quarter. Harvest Fund Management Co. Ltd now owns 177 shares of the company’s stock valued at $64,000 after acquiring an additional 107 shares during the period. Exane Derivatives acquired a new stake in shares of Chemed during the fourth quarter worth about $89,000. Panagora Asset Management Inc. boosted its stake in shares of Chemed by 613.7% in the second quarter. Panagora Asset Management Inc. now owns 364 shares of the company’s stock valued at $131,000 after purchasing an additional 313 shares during the period. Finally, Whittier Trust Co. increased its stake in Chemed by 71.1% during the 3rd quarter. Whittier Trust Co. now owns 325 shares of the company’s stock worth $136,000 after buying an additional 135 shares during the period. Hedge funds and other institutional investors own 88.81% of the company’s stock.
A number of research analysts have recently issued reports on CHE shares. Oppenheimer lifted their price target on Chemed from $440.00 to $470.00 and gave the company a “market perform” rating in a report on Monday, November 25th. ValuEngine cut shares of Chemed from a “hold” rating to a “sell” rating in a research report on Tuesday, December 3rd. Finally, JMP Securities raised Chemed from a “market perform” rating to an “outperform” rating and set a $490.00 target price on the stock in a research report on Friday, November 1st. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company. Chemed presently has an average rating of “Hold” and an average price target of $466.25.
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.